EUVIMEDEUVIMED entdecken
Crossref

Angiopoietin-like 4 Is a Critical Regulator of Fibroblasts during Pulmonary Fibrosis Development

Shoichiro Saito, Masahiro Kitabatake, Noriko Ouji-Sageshima, Tatsuro Ogawa, Akihisa Oda, Tomoko Nishimura, Tatsuki Nishioka, Satoki Fushimi, Atsushi Hara, Shigeyuki Shichino, Makiko Kumamoto, Shigeto Hontsu und 6 weitere

American Journal of Respiratory Cell and Molecular Biology · 2023

DOI: 10.1165/rcmb.2022-0304oc ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Respiratory Cell and Molecular Biology, 2023. Verfasst von Shoichiro Saito und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology. Hauptthemen laut MEDLINE: Angiopoietin-Like Protein 4, Fibroblasts, Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, JSPS Innovative Areas program, JSPS Grant-in-Aid for Transformative Research Areas program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and irreversible interstitial pneumonia caused by the excessive production and deposition of extracellular matrix components, including type I collagen. Activated fibroblasts, called α-SMA (α-smooth muscle actin)-expressing myofibroblasts, are the major source of type I collagen in pulmonary fibrosis (PF), but the mechanisms underlying disease progression have not been fully elucidated. Here, we obtained lung fibroblasts from patients with IPF from both nonfibrotic and fibrotic areas as determined by a lung computed tomography scan and compared gene expression between these areas by DNA microarray. We found that ANGPTL4 (angiopoietin-like 4) was highly expressed only in fibroblasts from the fibrotic area. ANGPTL4 was selectively expressed in the fibroblastic area of IPF lungs, where the myofibroblast marker α-SMA was also expressed. ANGPTL4 also regulates the gene expression of fibrosis-related markers, cell migration, and proliferation. In addition, ANGPTL4 expression in a murine model of PF induced by treatment with bleomycin was significantly induced in the lungs from the acute to the chronic phase. Single-cell transcriptome analysis during the course of bleomycin-induced PF revealed that Angptl4 was predominantly expressed in the activated fibroblasts and myofibroblasts. Moreover, the administration of recombinant ANGPTL4 to the bleomycin-induced fibrosis model significantly increased collagen deposition and exacerbated the PF. In contrast, the pathogenesis of PF in Angptl4-deficient mice was improved. These results indicate that ANGPTL4 is critical for the progression of PF and might be an early diagnostic marker and therapeutic target for IPF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiopoietin-Like Protein 4FibroblastsIdiopathic Pulmonary FibrosisPulmonary FibrosisAnimalsHumansBleomycinMiceLungMice, Inbred C57BLMyofibroblastsActinsMaleCell ProliferationCell MovementDisease Models, Animal

Stichwörter der Autor:innen

ANGPTL4myofibroblastpulmonary fibrosissingle-cell RNA sequencingtransforming growth factor-β

Substanzen

Angiopoietin-Like Protein 4BleomycinANGPTL4 protein, humanActins

Autor:innen und Institutionen

  • Department of Immunology.
  • Division of Molecular Regulation of Inflammatory and Immune Diseases, Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba, Japan.
  • Department of Pediatrics.
  • Department of Respiratory Medicine, and.
  • Department of Thoracic and Cardiovascular Surgery, Nara Medical University, Nara, Japan; and.

Förderung

  • Japan Society for the Promotion of Science
  • JSPS Innovative Areas program
  • JSPS Grant-in-Aid for Transformative Research Areas program
  • Japan Agency for Medical Research and Development PRIME program

Zitieren

APA

Saito, S., Kitabatake, M., Ouji-Sageshima, N., Ogawa, T., Oda, A., Nishimura, T., Nishioka, T., Fushimi, S., Hara, A., Shichino, S., Kumamoto, M., Hontsu, S., Kawaguchi, T., Ueha, S., Sawabata, N., Muro, S., Matsushima, K., & Ito, T. (2023). Angiopoietin-like 4 Is a Critical Regulator of Fibroblasts during Pulmonary Fibrosis Development. American Journal of Respiratory Cell and Molecular Biology. https://doi.org/10.1165/rcmb.2022-0304oc

Vancouver

Saito S, Kitabatake M, Ouji-Sageshima N, Ogawa T, Oda A, Nishimura T, et al. Angiopoietin-like 4 Is a Critical Regulator of Fibroblasts during Pulmonary Fibrosis Development. American Journal of Respiratory Cell and Molecular Biology. 2023. doi:10.1165/rcmb.2022-0304oc

BibTeX
@article{Saito2023,
  author = {Saito, Shoichiro and Kitabatake, Masahiro and Ouji-Sageshima, Noriko and Ogawa, Tatsuro and Oda, Akihisa and Nishimura, Tomoko and Nishioka, Tatsuki and Fushimi, Satoki and Hara, Atsushi and Shichino, Shigeyuki and Kumamoto, Makiko and Hontsu, Shigeto and Kawaguchi, Takeshi and Ueha, Satoshi and Sawabata, Noriyoshi and Muro, Shigeo and Matsushima, Kouji and Ito, Toshihiro},
  title = {Angiopoietin-like 4 Is a Critical Regulator of Fibroblasts during Pulmonary Fibrosis Development},
  journal = {American Journal of Respiratory Cell and Molecular Biology},
  year = {2023},
  doi = {10.1165/rcmb.2022-0304oc}
}
Kostenlos starten →